These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 23764374

  • 21. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
    Xu X, Prens E, Florencia E, Leenen P, Boon L, Asmawidjaja P, Mus AM, Lubberts E.
    Front Immunol; 2021; 12():719562. PubMed ID: 34616394
    [Abstract] [Full Text] [Related]

  • 22. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L, Failla CM, Capriotti L, Scarponi C, Facchiano F, Morelli M, Rossi S, Pagnanelli G, Albanesi C, Cavani A, Madonna S.
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [Abstract] [Full Text] [Related]

  • 23. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
    Yego EC, Dillman JF.
    Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
    [Abstract] [Full Text] [Related]

  • 24. The Keratinocyte Transcriptome in Psoriasis: Pathways Related to Immune Responses, Cell Cycle and Keratinization.
    Pasquali L, Srivastava A, Meisgen F, Das Mahapatra K, Xia P, Xu Landén N, Pivarcsi A, Sonkoly E.
    Acta Derm Venereol; 2019 Feb 01; 99(2):196-205. PubMed ID: 30320872
    [Abstract] [Full Text] [Related]

  • 25. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P, Saini N.
    Biochim Biophys Acta Mol Basis Dis; 2018 May 01; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [Abstract] [Full Text] [Related]

  • 26. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
    Tohyama M, Matsumoto A, Tsuda T, Dai X, Shiraishi K, Sayama K.
    J Dermatol Sci; 2021 Mar 01; 101(3):202-209. PubMed ID: 33509657
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. TNF-α and IL-17A induce the expression of lympho-epithelial Kazal-type inhibitor in epidermal keratinocytes.
    Sugihara S, Sugimoto S, Tachibana K, Kobashi M, Nomura H, Miyake T, Hirai Y, Yamasaki O, Morizane S.
    J Dermatol Sci; 2019 Oct 01; 96(1):26-32. PubMed ID: 31501002
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
    Wang M, Zhang S, Zheng G, Huang J, Songyang Z, Zhao X, Lin X.
    Immunity; 2018 Jul 17; 49(1):66-79.e5. PubMed ID: 29980436
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interleukin-17A suppresses granular layer formation in a 3-D human epidermis model through regulation of terminal differentiation genes.
    Sato E, Yano N, Fujita Y, Imafuku S.
    J Dermatol; 2020 Apr 17; 47(4):390-396. PubMed ID: 32020672
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis.
    Morelli M, Scarponi C, Mercurio L, Facchiano F, Pallotta S, Madonna S, Girolomoni G, Albanesi C.
    J Immunol Res; 2018 Apr 17; 2018():7897263. PubMed ID: 30581877
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SIRT5 reduces the inflammatory response and barrier dysfunction in IL-17A-induced epidermal keratinocytes.
    Wang C, He D, Shi C.
    Allergol Immunopathol (Madr); 2023 Apr 17; 51(1):30-36. PubMed ID: 36617819
    [Abstract] [Full Text] [Related]

  • 38. IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.
    Tohyama M, Hanakawa Y, Shirakata Y, Dai X, Yang L, Hirakawa S, Tokumaru S, Okazaki H, Sayama K, Hashimoto K.
    Eur J Immunol; 2009 Oct 17; 39(10):2779-88. PubMed ID: 19731362
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.